United States securities and exchange commission logo





                    January 25, 2024

       Xianchang Ma
       Chief Executive Officer and Chief Financial Officer
       Tengjun Biotechnology Corp.
       East Jinze Road and South Huimin Road
       Food Industry Economic and Technology Development District
       Jianxiang County, Jining City
       Shandong Province, China

                                                        Re: Tengjun
Biotechnology Corp.
                                                            Form 10-K for the
Year Ended December 31, 2022
                                                            Form 10-Q for the
Quarter Ended March 31, 2023
                                                            File No. 333-169397

       Dear Xianchang Ma:

               We issued comments to you on the above captioned filings on July
21, 2023. As of the
       date of this letter, these comments remain outstanding and unresolved.
We expect you to provide
       a complete, substantive response to these comments by February 8, 2024.

               If you do not respond, we will, consistent with our obligations
under the federal securities
       laws, decide how we will seek to resolve material outstanding comments
and complete our
       review of your filings and your disclosure. Among other things, we may
decide to release
       publicly, through the agency's EDGAR system, all correspondence,
including this letter, relating
       to the review of your filings, consistent with the staff's decision to
publicly release comment and
       response letters relating to disclosure filings it has reviewed.

              Please contact SiSi Cheng at 202-551-5004 or Ernest Greene at
202-551-3733 with any
       questions.




                    Sincerely,


                    Division of Corporation Finance

                    Office of Manufacturing
       cc:                                              Huan Lou, Esq.